Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07623941 · ClinicalTrials.gov registry record
CUIMC Focal Therapy Registry
A clinical trial, sponsored by Columbia University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
NCT07623941: Recruiting study, sponsored by Columbia University.
NCT07623941 is a clinical trial that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07623941 is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Patients undergoing high intensity focused ultrasound (HIFU) or irreversible electroporation (IRE) for prostate cancer will be invited to consent to have their data collected in a detailed comprehensive system to record and store patient, disease, and treatment-related characteristics. No treatment will be given, no randomization will occur, and each patient seen and treated for prostate cancer specifically with HIFU and IRE method in the Department of Urology division of Urologic Oncology within Columbia University Irving Medical Center will be eligible to be enrolled in the database.
Interventions
- PROCEDURE Focal therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2040-12-31 |
What NCT07623941 shows while recruiting
NCT07623941 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Focal therapy is the first listed.
NCT07623941 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07623941 about?
NCT07623941 is a clinical study titled "CUIMC Focal Therapy Registry". Patients undergoing high intensity focused ultrasound (HIFU) or irreversible electroporation (IRE) for prostate cancer will be invited to consent to have their data collected in a detailed comprehensive system to record and store patient, disease, and treatment-related characteristics. No treatment ...
What is the current status of trial NCT07623941?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-01-01. Estimated completion is 2040-12-31.
What interventions are being tested in trial NCT07623941?
The interventions under investigation include: Focal therapy (PROCEDURE).
Who is sponsoring clinical trial NCT07623941?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI